RCE 3.19% 48.5¢ recce pharmaceuticals ltd

News: RCE Recce Pharmaceuticals Gets Ethics Approval To Start Phase 1 Intravenous Clinical Trial, page-41

  1. 5,382 Posts.
    lightbulb Created with Sketch. 692
    Jeez feels like we're just waiting for the news to drop now. Majority of shorts still seem to still be happy holding their position despite news on burns trial having clearly been stated as expected "within weeks"
    Last update was strange as it stated a list of bacteria that "we have encountered so far" in burns trial yet gave no indication of how we had fared. Also mentioned biofilms, which I feel are going to be a big factor in this trial. I believe Rce stated they had shown effect against gram negative bacteria and biofilms in previous separate updates but this will be the real test. I wonder what sort of Christmas present we are about to get??

    I am curious why they stated early on there would be ongoing data release as rhe trial progressed, yet this has not been the case up until now. Surely by now the trial is pretty much done as it was 30 patients at 2 weeks each?
    Last edited by andrewk65: 03/12/21
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
48.5¢
Change
0.015(3.19%)
Mkt cap ! $112.4M
Open High Low Value Volume
47.5¢ 49.0¢ 47.5¢ $83.1K 172.3K

Buyers (Bids)

No. Vol. Price($)
4 110909 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.5¢ 17499 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.